# FDA Inspection 1162453 - Tomasz Huzarski, MD, PhD - January 27, 2022

Source: https://www.keypedia.com/records/fda_inspections/tomasz-huzarski-md-phd/c2aa2352-fff1-42f9-8b96-82fdee8aff66
Source feed: FDA_Inspections

> FDA Inspection 1162453 for Tomasz Huzarski, MD, PhD on January 27, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162453
- Company Name: Tomasz Huzarski, MD, PhD
- Inspection Date: 2022-01-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/tomasz-huzarski-md-phd/164f78b3-abb6-464a-b8ad-46f91f73f331

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c